Tadataka Yamada

Insider Reports History

Identity
Location
Mansfield, MA
SEC record
Reporting signature
/s/ Thomas Russo, Attorney-in Fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Tadataka Yamada:

Form 4 holding Director

Icosavax, Inc.

Security class
Common Stock
Shares / value
627,229
Estimated value
$9,830,247
Report date
28 Jul 2021
Price
$15.67
Ownership
By Leslie D. Yamada 2016 Trust
Form 4 holding Director

Icosavax, Inc.

Security class
Common Stock
Shares / value
124,097
Estimated value
$1,944,910
Report date
28 Jul 2021
Price
$15.67
Ownership
Direct
Form 4 holding Director

Passage BIO, Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
16,918
Estimated value
Report date
27 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Athira Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
13,871
Estimated value
Report date
28 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Phathom Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,500
Estimated value
Report date
21 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Tadataka Yamada

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .